Michael Shen

22PUBLICATIONS
115CO-AUTHORS
Molecular targetsPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cancer cell biologyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 01, 2026
Retraction Note: NSD2 targeting reverses plasticity and drug resistance in prostate cancer.

|May 28, 2026
A forward genetic screen identifies Sirtuin1 as a driver of neuroendocrine prostate cancer.

|Nov 26, 2025
NSD2 targeting reverses plasticity and drug resistance in prostate cancer.

Jia J Li, Alessandro Vasciaveo, Dimitris Karagiannis

|Apr 09, 2025
The regulatory architecture of the primed pluripotent cell state.

Bo I Li, Mariano J Alvarez, Hui Zhao

|Dec 05, 2024
Rarγ-Foxa1 signaling promotes luminal identity in prostate progenitors and is disrupted in prostate cancer.

Dario De Felice, Alessandro Alaimo, Davide Bressan

|Feb 14, 2024
Meta-analyses of mouse and human prostate single-cell transcriptomes reveal widespread epithelial plasticity in tissue regression, regeneration, and cancer.

Luis Aparicio, Laura Crowley, John R Christin

Pageof 4

Frequent Collaborators

6 joint publications

Andrea Califano

5 joint publications

Alessandro Vasciaveo

4 joint publications

Cory Abate-Shen

4 joint publications

Mark A Rubin